AGEN has been in the news 643% more than usual
Sep 18, 2024, 2:31 PM
-27.00%
What does AGEN do
Agenus, a US-based biotechnology company headquartered in Lexington, specializes in immuno-oncology therapies targeting cancer and infectious diseases, employing 389 staff. Its pipeline includes advanced antibodies and various immunotherapy classes.
AGEN has been in the news recently: GSK plc reported positive phase 3 trial results indicating that the co-administration of its AREXVY and SHINGRIX vaccines in adults aged 50 and older elicited effective immune responses while demonstrating safety and tolerability. The trials confirmed that the immune response was non-inferior when both vaccines were given together.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.